The Centers for Medicare & Medicaid Services under the U.S. Department of Health and Human Services has authorized Myomo Inc to be a Medicare Provider.

Myomo is now included in the Medicare Supplier Directory at, and this designation enables Myomo to bill Medicare directly when it delivers its MyoPro powered orthosis in 39 states plus D.C. The company is working to complete the requirements in the remaining states, it notes in a media release.

“This certification is very important to Myomo. Not only does it allow us to bill Medicare directly in the future, it also opens the door to applying for in-network contracted coverage from many private commercial insurance companies as well as state Medicaid plans.”

— Micah Mitchell, Myomo’s Chief Commercial Officer

“Today, reimbursement for the MyoPro orthosis is approved on a case-by-case basis by many Medicare Advantage plans, state Blue Cross / Blue Shield plans, certain Medicaid and commercial insurance plans, worker’s compensation plans, and the Veterans Administration. Obtaining broader coverage would allow us to potentially better serve the qualifying beneficiaries of Medicare and other plans who suffer a paralyzed or weakened arm caused by stroke or nerve injury.

“I want to emphasize that we have not yet received coverage or reimbursement terms from CMS, and in fact there is no guarantee those terms will be forthcoming soon, but Provider status is an important step following on to our receiving Healthcare Common Procedure Coding System (HCPCS) codes from CMS last year. We will continue to advocate for MyoPro coverage to help appropriate candidates obtain this useful technology for use at home, at work, and in school.”

— Paul R. Gudonis, Myomo CEO

[Source(s): Myomo Inc, Business Wire]

Related Content:
Myomo’s MyoPro Issued New Patents
Myomo Launches MyoCare for First-Year MyoPro Users
Myomo Signs Payor Agreement with HOMELINK for Orthosis Claims